AZD4901 (oral) + Placebo to match AZD4901
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder
Conditions
Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder
Trial Timeline
Jun 1, 2013 → Jul 1, 2014
NCT ID
NCT01872078About AZD4901 (oral) + Placebo to match AZD4901
AZD4901 (oral) + Placebo to match AZD4901 is a phase 2 stage product being developed by AstraZeneca for Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT01872078. Target conditions include Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01872078 | Phase 2 | Completed |
Competing Products
20 competing products in Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder